A study of DKN-01 in patients with endometrioid gynecological cancers

Trial Profile

A study of DKN-01 in patients with endometrioid gynecological cancers

Planning
Phase of Trial: Phase II

Latest Information Update: 13 Nov 2017

At a glance

  • Drugs DKN 01 (Primary)
  • Indications Endometrial cancer; Gynaecological cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Nov 2017 According to a Leap Therapeutics media release, the company has filed an IND application with the FDA to initiate this trial.
    • 17 Aug 2017 New trial record
    • 11 Aug 2017 According to a Leap Therapeutics media release, the company anticipates initiating this trial in 2H 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top